Kelly Echevarria
- Infectious Diseases top 5%
- Epidemiology
- Applied Microbiology and Biotechnology top 1%
- Clinical Biochemistry top 5%
- Pharmacology top 10%
- Co-authors
- James S. LewisThomas C. HardinJean A. SmithJason E. BowlingDarrel W. HughesPamela R. MaxwellGary A. RoselleAnthony P. Morreale
- Topics
- Antibiotic Use and Resistance (13 papers)Antimicrobial Resistance in Staphylococcus (9 papers)Antibiotics Pharmacokinetics and Efficacy (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesAustralia
In The Last Decade
Kelly Echevarria
32 papers receiving 620 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 337
- Epidemiology 236
- Applied Microbiology and Biotechnology 187
- Clinical Biochemistry 147
- Pharmacology 113
Countries citing papers authored by Kelly Echevarria
This map shows the geographic impact of Kelly Echevarria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Echevarria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Echevarria more than expected).
Fields of papers citing papers by Kelly Echevarria
This network shows the impact of papers produced by Kelly Echevarria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Echevarria. The network helps show where Kelly Echevarria may publish in the future.
Co-authorship network of co-authors of Kelly Echevarria
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Echevarria. A scholar is included among the top collaborators of Kelly Echevarria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Echevarria. Kelly Echevarria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 15 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 69 | |
| 15 | 18 | |
| 16 | 93 | |
| 17 | Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia | 1 |
| 18 | 15 | |
| 19 | 62 | |
| 20 | 37 |
About Kelly Echevarria
Kelly Echevarria is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Clinical Biochemistry, having authored 33 papers that have together received 638 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (187 citations), Clinical Biochemistry (147 citations) and Infectious Diseases (337 citations). Kelly Echevarria has collaborated with scholars based in United States and Australia. Frequent co-authors include James S. Lewis, Thomas C. Hardin, Jean A. Smith, Jason E. Bowling, Darrel W. Hughes, Pamela R. Maxwell, Gary A. Roselle, Anthony P. Morreale, Melinda M. Neuhauser and Makoto Jones. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.